You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 040405


✉ Email this page to a colleague

« Back to Dashboard


NDA 040405 describes ANEXSIA 7.5/325, which is a drug marketed by Specgx Llc and is included in one NDA. It is available from five suppliers. Additional details are available on the ANEXSIA 7.5/325 profile page.

The generic ingredient in ANEXSIA 7.5/325 is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for 040405
Tradename:ANEXSIA 7.5/325
Applicant:Specgx Llc
Ingredient:acetaminophen; hydrocodone bitartrate
Patents:0
Pharmacology for NDA: 040405
Mechanism of ActionOpioid Agonists
Suppliers and Packaging for NDA: 040405
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANEXSIA 7.5/325 acetaminophen; hydrocodone bitartrate TABLET;ORAL 040405 ANDA SpecGx LLC 0406-0124 0406-0124-01 100 TABLET in 1 BOTTLE (0406-0124-01)
ANEXSIA 7.5/325 acetaminophen; hydrocodone bitartrate TABLET;ORAL 040405 ANDA SpecGx LLC 0406-0124 0406-0124-05 500 TABLET in 1 BOTTLE (0406-0124-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;7.5MG
Approval Date:Sep 8, 2000TE:AARLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.